Share Exchange Agreements

This SHARE EXCHANGE AGREEMENT (the “agreement”) will be concluded on August 10, 2016 by and between CORRECTIVE BIOTECHNOLOGIES, INC., a Wyoming company (“Biotechnologies”), with offices in 605 W. Knox Rd., Suite 202 Tempe, AZ 85284, BIOMODELING SOLUTIONS, INC., an Oregon company with offices in 17933 NW Evergreen Pkwy., Suite 280 Beaverton, OR 97006 (“BioModeling”), BioModeling shareholders listed on the signature page , FIRST VIVOS, INC., a Texas-based company with operations in 514 Country Lane, Coppell, TX 75019 (“Vivos”) and Vivos shareholders on the signature page (Vivos shareholders) on the following terms (BioModeling and Vivos are collectively referred to as “acquired companies”): this definitive share exchange agreement (“agreement”), dated May 28, 2020, is owned by cXJ Investment Group Company Limited (“CXJ”) , a company of the British Virgin Islands , issue 2031896, based at OMC Chambers, Wickhams Cay 1, Road Town, Tortola, British Virgin Islands. New Charles Technology Group Limited, the sole shareholder of CXJ (the shareholder), and CXJ Group Co., Limited, a Nevada company (“ECXJ”), located at 50 West Liberty Street, Suite 880, Reno, NV 89501, and Lixin Cai, Managing Director of ECXJ (“Cai”). Together, the shareholders of CXJ, ECXJ and Cai are the “parties.” This final share exchange agreement (“agreement”) of June 29, 2020 is part of Futuris Technology Services, Inc. (“Futuris”), a Virginia-based company at 4506 Daly Drive, Suite-100, Chantilly VA 20151 (the sole owner of Pioneer Global Inc., a Virginia company (“Pioneer”), the shareholders of Futuris (together the “shareholders”) and Mission Mining Co., a Wyoming company (“MISM”), located on Baltimore Road 22. , Rockville, MD 20850, and Kalyan Pathuri, President of MISM (“Pathuri”). Together, the shareholders, Futuris, MISM and Pathuri are the “parties”. This share exchange agreement (this “agreement”) is concluded at the time of the first date (effective date) of and between (i) Sollensys Corp. and a Nevada company (the “company”); (ii) Eagle Lake Laboratories, Inc., a Florida company (“Eagle Lake”), (iii) of each Eagle Lake shareholder, as stated on the signature pages (the “Eagle Lake Shareholders”) and (iv) Donald Beavers as a representative of Eagle Lake shareholders (the “shareholder representatives”).